Presence of risk factors associated with colectomy among patients with ulcerative colitis: a analysi...
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program
About this item
Full title
Author / Creator
Publisher
SAGE Publishing
Journal title
Language
English
Formats
Publication information
Publisher
SAGE Publishing
More information
Scope and Contents
Contents
Background: Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Objective: To assess colectomy incidence rates (IRs) and baseline characteristics for the presence of identified colectomy risk factors among patients in the tofacitinib OCTAVE UC clinical program. Design: This post hoc analysis ev...
Alternative Titles
Full title
Presence of risk factors associated with colectomy among patients with ulcerative colitis: a analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4f14d6481d204724942026dae5b142a5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4f14d6481d204724942026dae5b142a5
Other Identifiers
E-ISSN
1756-2848
DOI
10.1177/17562848231189122
